FDA Approved: TREPROSTINIL — Original Application (Teva Parenteral Medicines, Inc.)

View source ↗

Summary

FDA approved Teva Parenteral Medicines’ TREPROSTINIL as an Original Application, confirming a generic treprostinil product for pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

ORIG AP for TREPROSTINIL (TREPROSTINIL)